Publications

ssessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.

Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists' (CTT) Collaboration ., (2026), Lancet

ssessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets.

Mihaylova B. et al, (2024), Health Technol Assess, 28, 1 - 134

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study.

Mihaylova B. et al, (2024), Heart, 110, 1277 - 1285

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists’ (CTT) Collaboration ., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319

Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study.

Mihaylova B. et al, (2024), Lancet Reg Health Eur, 40

Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP).

Herrington WG. et al, (2023), Kidney Int Rep, 8, 1489 - 1495

ccelerating clinical trials: time to turn words into action.

Landray MJ. et al, (2023), Lancet, 402, 165 - 168

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.

Zhou J. et al, (2023), Pharmacoeconomics, 41, 547 - 559

Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association's Scientific Sessions 2022 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2022.

(2022), Circulation, 146, e569 - e605

Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.

Cholesterol Treatment Trialists' Collaboration ., (2022), Clin Trials, 19, 593 - 604

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration ., (2022), Lancet, 400, 832 - 845

ngiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.

Pitcher A. et al, (2022), Lancet, 400, 822 - 831

Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy

BAIGENT C. et al, (2022), The Lancet

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative Group ., (2022), Lancet, 400, 359 - 368

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2022), Lancet, 399, 665 - 676

Search results (66)